Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Regional analysis and genetic association of nigrostriatal degeneration in Lewy body disease.

Kasanuki K, Heckman MG, Diehl NN, Murray ME, Koga S, Soto A, Ross OA, Dickson DW.

Mov Disord. 2017 Nov;32(11):1584-1593. doi: 10.1002/mds.27184. Epub 2017 Sep 26.

2.

Association of MAPT H1 subhaplotypes with neuropathology of lewy body disease.

Heckman MG, Kasanuki K, Brennan RR, Labbé C, Vargas ER, Soto AI, Murray ME, Koga S, Dickson DW, Ross OA.

Mov Disord. 2019 Jun 24. doi: 10.1002/mds.27773. [Epub ahead of print]

PMID:
31234228
3.

Disease duration and the integrity of the nigrostriatal system in Parkinson's disease.

Kordower JH, Olanow CW, Dodiya HB, Chu Y, Beach TG, Adler CH, Halliday GM, Bartus RT.

Brain. 2013 Aug;136(Pt 8):2419-31. doi: 10.1093/brain/awt192.

4.

Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?

Tsuboi Y, Dickson DW.

Parkinsonism Relat Disord. 2005 Jun;11 Suppl 1:S47-51.

PMID:
15885629
5.

Incidental Lewy body disease and preclinical Parkinson disease.

DelleDonne A, Klos KJ, Fujishiro H, Ahmed Z, Parisi JE, Josephs KA, Frigerio R, Burnett M, Wszolek ZK, Uitti RJ, Ahlskog JE, Dickson DW.

Arch Neurol. 2008 Aug;65(8):1074-80. doi: 10.1001/archneur.65.8.1074.

PMID:
18695057
6.
7.

Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.

Theisen F, Leda R, Pozorski V, Oh JM, Adluru N, Wong R, Okonkwo O, Dean DC 3rd, Bendlin BB, Johnson SC, Alexander AL, Gallagher CL.

Neuroimage Clin. 2017 Sep 9;16:557-563. doi: 10.1016/j.nicl.2017.09.009. eCollection 2017.

8.

[Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].

Orimo S.

Rinsho Shinkeigaku. 2008 Jan;48(1):11-24. Review. Japanese.

PMID:
18386627
9.

The nigro-striatal and nigro-amygdaloid pathways undergo different degeneration processes in brains of dementia with Lewy bodies.

Iseki E, Marui W, Yamamoto R, Togo T, Katsuse O, Kato M, Iwatsubo T, Kosaka K, Arai H.

Neurosci Lett. 2005 May 20-27;380(1-2):161-5. Epub 2005 Feb 3.

PMID:
15854770
10.

Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism.

Hauser MA, Li YJ, Xu H, Noureddine MA, Shao YS, Gullans SR, Scherzer CR, Jensen RV, McLaurin AC, Gibson JR, Scott BL, Jewett RM, Stenger JE, Schmechel DE, Hulette CM, Vance JM.

Arch Neurol. 2005 Jun;62(6):917-21.

PMID:
15956162
11.

Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease.

Milber JM, Noorigian JV, Morley JF, Petrovitch H, White L, Ross GW, Duda JE.

Neurology. 2012 Dec 11;79(24):2307-14. doi: 10.1212/WNL.0b013e318278fe32. Epub 2012 Nov 14.

12.
13.

Substantia nigra Marinesco bodies are associated with decreased striatal expression of dopaminergic markers.

Beach TG, Walker DG, Sue LI, Newell A, Adler CC, Joyce JN.

J Neuropathol Exp Neurol. 2004 Apr;63(4):329-37.

PMID:
15099023
14.

AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.

Ip CW, Klaus LC, Karikari AA, Visanji NP, Brotchie JM, Lang AE, Volkmann J, Koprich JB.

Acta Neuropathol Commun. 2017 Feb 1;5(1):11. doi: 10.1186/s40478-017-0416-x.

15.

The relationship of Alzheimer-type pathology to dementia in Parkinson's disease.

Jendroska K.

J Neural Transm Suppl. 1997;49:23-31. Review.

PMID:
9266411
16.
17.
18.

Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease.

Dickson DW, Fujishiro H, DelleDonne A, Menke J, Ahmed Z, Klos KJ, Josephs KA, Frigerio R, Burnett M, Parisi JE, Ahlskog JE.

Acta Neuropathol. 2008 Apr;115(4):437-44. doi: 10.1007/s00401-008-0345-7. Epub 2008 Feb 9.

PMID:
18264713
19.

Morphological substrates of mental dysfunction in Lewy body disease: an update.

Jellinger KA.

J Neural Transm Suppl. 2000;59:185-212.

PMID:
10961431
20.

Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction.

Beach TG, Adler CH, Lue L, Sue LI, Bachalakuri J, Henry-Watson J, Sasse J, Boyer S, Shirohi S, Brooks R, Eschbacher J, White CL 3rd, Akiyama H, Caviness J, Shill HA, Connor DJ, Sabbagh MN, Walker DG; Arizona Parkinson's Disease Consortium.

Acta Neuropathol. 2009 Jun;117(6):613-34. doi: 10.1007/s00401-009-0538-8. Epub 2009 Apr 28.

Supplemental Content

Support Center